MPN Advances Day 2019 | New therapies for MPNs: an update before ASH
Claire Harrison, MD, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, highlights the range of new therapies for myeloproliferative neoplasms (MPNs) and what they can offer. This includes JAK, LSD1 and MDM2 inhibitors, among other strategies. This interview took place at the MPN Advances Day 2019 in London, UK.
Get great new content delivered to your inboxSign up